ATTENTION deficit hyperactivity
disorder (ADHD) may be the
subject of overprescription and
overdiagnosis with the implication
that disorders of children in
particular are being “medicalised”,
according to an editorial in the
MJA.
There are risks for children that
the use of stimulant medication is a
“simplistic attempt to find solutions
to more complex problems
underlying behavioural and
emotional difficulties, and risks in
adolescents and adults prescribed
or exposed to stimulants, including
poisonings,” the article states.
The author suggests that
prescription monitoring programs
may have a role to play, although
this has not generally been
successful in Australia as yet.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Mar 16
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.